Abstract: The present invention relates to a disinfectant composition comprising hydrogen peroxide and silver ions in association with at least one quaternary ammonium salt with biocidal action and compatible with silver ions. The composition can be used for disinfecting a room and any objects contained therein, in particular healthcare environments, such as, for example, laboratories, doctors' surgeries, hospital rooms, ambulance compartments and the like, where it is important to have a biocidal activity at low dosages proportional to the average contamination present.
Abstract: Described herein are injectable corticosteroid-loaded microparticles, pharmaceutical composition thereof and methods for reducing inflammation or pain in a body compartment such as a joint, an epidural space, a vitreous body of an eye, a surgically created space, or a space adjacent to an implant.
Type:
Grant
Filed:
May 9, 2018
Date of Patent:
January 11, 2022
Inventors:
James A. Helliwell, Amanda M. Malone, Thomas J. Smith, Marc M. Baum
Abstract: Disclosed herein are tooth whitening compositions comprising at least one hydrophobic polymer carrier; fumed silica; sorbitan sebacate behenate polymer; and at least one whitening agent, wherein the tooth whitening composition has a structural parameter such that G?/G? is greater than or equal to about 1. Also disclosed herein are methods of making a tooth whitening composition and methods of whitening the surface of a tooth.
Abstract: A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of water soluble drug in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to the drug.
Type:
Grant
Filed:
April 4, 2017
Date of Patent:
November 2, 2021
Assignee:
APRECIA PHARMACEUTICALS LLC
Inventors:
Jules Jacob, Norman Coyle, Thomas G. West, Donald C. Monkhouse, Henry L. Surprenant, Nemichand B. Jain
Abstract: A method for producing starch soft capsules comprises the following steps: preparing a mixture comprising starch, plasticizer and water, wherein more than 50 weight percent of the starch is present in the form of particles of granular starch; shaping the mixture to form a film in a shaping process; solidifying the mixture by increasing the temperature of the mixture during and/or after the shaping process by more than 5° C.; and shaping the film to form a soft capsule. Soft capsules produced by this method have starch particles bonded to one another. A device for performing this method comprises a shaping device to enable shaping of the starch material to form a film, and a heating device to perform a heat treatment to destructure the starch during and/or after the shaping. It comprises a rotary die device.
Abstract: This invention relates to oral care compositions comprising a zinc source comprising zinc oxide and zinc citrate; a stannous source comprising stannous pyrophosphate; a fluoride ion source comprising sodium fluoride; and an organic buffer, as well as to methods of using and of making these compositions.
Type:
Grant
Filed:
September 19, 2017
Date of Patent:
October 26, 2021
Assignee:
Colgate-Palmolive Company
Inventors:
Aarti Rege, Michael Prencipe, Paul Thomson
Abstract: The present invention relates to a verification method of tablets, in particular pharmaceutical tablets. It further relates to an invisible secure marking or information which is a part of such tablet. The invention further relates to tablets suitable for such verification method, to processes for manufacturing such tablets and methods for reading the information.
Abstract: A pharmaceutical composition comprises multiparticulates comprising a melt-congeal core and a solid amorphous dispersion layer of a poorly water soluble drug and polymer. The multiparticulates are suitable for improving bioavailability of poorly water soluble drugs. The melt-congeal cores facilitate application of the solid amorphous dispersion layer, and allow incorporation of additional optional components to the core so as to adjust the release of drug from the multiparticulate.
Type:
Grant
Filed:
June 13, 2019
Date of Patent:
September 14, 2021
Assignee:
Bend Research, Inc.
Inventors:
Dwayne Thomas Friesen, Leah E. Appel, Joshua Richard Shockey, Sanjay Konagurthu, Edward Dennis LaChapelle
Abstract: The present disclosure relates to formulation for a teeth-cleaning product and a process for creating the formulation. Coconut milk and citrus pith are mixed into a formulation and heated upon a heat source until substantially boiling. Sodium bicarbonate and sodium carbonate are mixed into the formulation. Next, ethanol and hydrogen peroxide are added to the formulation. The formulation is removed from the heat source, then apple flesh and sodium chloride are added to the formulation. The formulation is allowed to cool. Next, peppermint oil and honey are added.
Abstract: The present invention relates to a method for producing a liquid composition for oral cavity in which ?-glycyrrhetinic acid is stably dispersed or dissolved to exhibit an increased transparency and which also can ensure a sufficient amount of ?-glycyrrhetinic acid adsorbed on gingiva, even if the amount of a cationic surfactant or an anionic surfactant is restricted; and such a liquid composition for oral cavity. Specifically, the present invention relates to a method for producing a liquid composition for oral cavity, comprising the following step 1 to step 4: (Step 1) a step of blending water (F) with an organic acid and a salt thereof (E) to adjust the pH of a resultant mixture to 5 or more and 6.8 or less, (Step 2) a step of blending 0.02% by mass or more and 0.1% by mass or less of cetylpyridinium chloride (B) into the mixture, (Step 3) a step of blending 0.02% by mass or more and 0.
Abstract: The invention provides multilayer tablets that contain rilpivirine hydrochloride, emtricitabine, and tenofivir disoproxil fumarate. The tablets are useful for the treatment of HIV.
Abstract: A method is provided of making a medicinal delivery system which satiates a craving in an individual when the medicinal delivery system is administered orally to the individual. A coating composition is applied on a saliva-soluble powder to establish a coated powder, the coating composition featuring an at least partially solubilized craving satiation medicinal compound. The coated powder is combined with an edible carrier base to establish a medicinal delivery system that rapidly releases medicine and buffer preferably followed by slower, sustained release.
Type:
Grant
Filed:
February 4, 2014
Date of Patent:
October 13, 2020
Assignee:
JSRNTI, LLC
Inventors:
Tommy L. Chau, John M. Pinney, Jack E. Henningfield, Edward J. Cone, Saul M. Shiffman, Joseph G. Gitchell
Abstract: Provided are nutritional supplements designed for enhancing the growth, particularly the linear growth, of pre-pubertal children with a stature measure short compared to the norm. The nutritional composition includes an energy source, arginine and a combination of micronutrients.
Abstract: A soft film, a sponge, or a sheet in the dried state is provided, which is capable of forming a hydrogel absorbing water or blood. The film is obtainable by preparing a film-state material in the dried state from either a solution of poly(acrylic acid) or a solution of polyvinylpyrrolidone, and bringing the film-state material into contact with the other remaining solution, and then drying or freeze-drying it.
Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
Type:
Grant
Filed:
November 6, 2019
Date of Patent:
June 23, 2020
Assignee:
CutisPharma, Inc.
Inventors:
Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
Abstract: Solid disinfectant dosage forms having a peroxy activator and a peroxy compound are provided. The dosage form can be selected so that addition of the dosage form to a predetermined quantity of water produces a disinfectant solution containing peracetic acid in a concentration of at least about 1000 ppm. The dosage form can include a colour indicator arranged to provide a first colour signal when the concentration of peracetic acid is lower than about 1000 ppm and a second colour signal when the concentration is higher than about 1000 ppm and a third colour signal when the concentration falls below about 1000 ppm. The peroxy compound can be selected from the group consisting of sodium percarbonate, ammonium persulphate, calcium percarbonate, magnesium percarbonate, sodium perborate, sodium persulfate, sodium perphosphate and mixtures thereof.
Abstract: The present invention relates to a polymeric material having one or more nanoparticles embedded within the surface layer of a single side of the material. In some embodiments, the nanoparticles are microbiocidal nanoparticles which impart antimicrobial characteristics to the polymeric material within which they sprayed and pushed by are embedded.
Type:
Grant
Filed:
March 16, 2012
Date of Patent:
April 21, 2020
Assignees:
University of Limerick, Wroclaw Medical University, Wroclaw University of Technology
Inventors:
Tofail Syed, Jacek Zeglinski, Patrick Cronin, Halina Podbielska, Ewa Dworniczek, Peter Tiernan, Roman Franiczek, Igor Buzalewicz, Magdalena Wawrzynska
Abstract: A prosthesis comprising a water-dissolvable coating. A prosthesis for a lacrimal canaliculus comprising a swellable punctal plug with a proximal end and a distal end, with the plug comprising a water-dissolvable biocompatible coating on the distal and/or the proximal end. Materials and methods for making and using the same. A prosthesis for placement in or across natural or prosthetic lumens, ostia, ducts, sinus, or sphincters, the prosthesis comprising a coating. The prosthesis can further provide a depot for sustained drug delivery to tissue.
Type:
Grant
Filed:
July 22, 2016
Date of Patent:
April 14, 2020
Assignee:
Incept, LLC
Inventors:
Peter Jarrett, Amarpreet S. Sawhney, Michael J. McGrath, Arthur Driscoll, Ankita D. Desai, Michael Bassett
Abstract: The present invention provides cosmetic formulations for improving the appearance of the skin, particularly the lips. The compositions of the invention provide multiple enhanced technologies that work synergistically to enhance hydration and appearance of the skin. Anti-aging peptides and tissue respiratory factor work together in an HA rich environment to enhance collagen and elastin while beneficial antioxidants protect HA in the lip from damaging exposure.
Abstract: The use of poly(oxyethylene)-poly(oxybutylene) block copolymers in pharmaceutical compositions useful for modifying the surfaces of contact lenses and other medical devices is disclosed. The present invention is based in-part on a discovery that this class of compounds is particularly efficient in wetting hydrophobic surfaces, such as the surfaces of silicone hydrogel contact lenses and other types of ophthalmic lenses. Such compounds are also useful for cleaning purposes. The use of the compounds as surfactants in various types of compositions for treating contact lenses therefore represents a preferred embodiment of the present invention.
Type:
Grant
Filed:
January 5, 2017
Date of Patent:
March 10, 2020
Assignee:
Alcon Inc.
Inventors:
Howard Allen Ketelson, Nathaniel D. McQueen